Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot StudySameek Roychowdhury, Arul M. Chinnaiyan, Matthew K. Iyer et al.|Science Translational Medicine|2011Cited by 637
Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal MelanomaRichard D. Carvajal, Gary K. Schwartz, Jeffrey A. Sosman et al.|JAMA|2014Cited by 429
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC studyAxel Hauschild, Jeannie Hou, Edward McKenna et al.|BMC Cancer|2017Cited by 412
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E2607)Kevin Kalinsky, John M. Kirkwood, Krista M. Rubin et al.|Cancer|2017Cited by 125
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced MyocarditisAlexi Vasbinder, Salim S. Hayek, YeeAnn Chen et al.|JACC CardioOncology|2022Cited by 78